Home > Specialties > IVD Test Reagent/Kits, Immunoassay, Tumor Marker, Receptor Assay, Progesterone

IVD Test Reagent/Kits, Immunoassay, Tumor Marker, Receptor Assay, Progesterone

Definition : Immunoassay reagents intended to perform qualitative and/or quantitative analyses in tissue preparations to determine the presence of a cellular regulatory protein that binds progesterone hormones (i.e., cytoplasmic progesterone receptors). These receptors are especially found in progesterone-sensitive tissues (e.g., breast, uterus, pituitary gland). The assays are usually performed in surgically removed samples; determination of the level of progesterone receptors is used in the prognosis of the response to endocrine therapy (i.e., it is a marker) in diseases such as breast cancer.

Entry Terms : "Progesterone Reagents, Receptor Assay" , "Reagents, Immunoassay, Tumor Marker, Receptor Assay, Progesterone"

UMDC code : 19710

U.S.companies only
Suppress Subsidiary Companies

1-3 of 3 Match(es).

Cancer Diagnostics Inc

Company Type: Parent

Cancer Diagnostics, Inc. (CDI)  manufactures, develops, and supplies products for the worldwide anatomical pathology market.

DRG International Inc

Company Type: Parent

DRG International, Inc. is a leading specialty medical diagnostics and equipment manufacturer, and distributor with operations in more than 110 countries. Founded in 1970, DRG International provides a complete range of products and services to the diagnostics and cardiology-related medical community. DRG International's global headquarters is based in Mountainside, New Jersey

Empire Genomics

Company Type: Parent

1-3 of 3 Match(es).


Medical Product Guide Ophthalmology Management Product Guide